Global Irritable Bowel Syndrome Pipeline Highlights 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Irritable Bowel Syndrome Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering.

Irritable Bowel Syndrome Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Irritable Bowel Syndrome market.

It covers emerging therapies for Irritable Bowel Syndrome in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Irritable Bowel Syndrome pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Irritable Bowel Syndrome pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Irritable Bowel Syndrome pipeline products by the company.

Short-term Launch Highlights:

Find out which Irritable Bowel Syndrome pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Irritable Bowel Syndrome phase 3 clinical trial pipeline products
  • Irritable Bowel Syndrome phase 2 clinical trial pipeline products
  • Irritable Bowel Syndrome phase 1 clinical trial pipeline products
  • Irritable Bowel Syndrome preclinical research pipeline products
  • Irritable Bowel Syndrome discovery stage pipeline products
  • Irritable Bowel Syndrome pipeline products short-term launch highlights

For more information about this report visit https://www.researchandmarkets.com/research/q37ds3/global_irritable?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs